XML 34 R23.htm IDEA: XBRL DOCUMENT v3.20.2
SHAREHOLDERS' EQUITY
 6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
SHAREHOLDERS' EQUITY
NOTE 15. SHAREHOLDERS’ EQUITY
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
Three months ended June 30
 
Six months ended June 30
(In millions)
2020

2019

 
2020

2019

Beginning balance
$
20

$
(16
)
 
$
61

$
(39
)
AOCI before reclasses – net of taxes of $8, $(23), $7 and $15(a)
34

94

 
41

121

Reclasses from AOCI – net of taxes of $(2), $(5), $(14) and $(6)
(7
)
(18
)
 
(55
)
(22
)
AOCI
27

76

 
(14
)
99

Less AOCI attributable to noncontrolling interests
—

—

 
—

1

Investment securities AOCI ending balance
$
47

$
60

 
$
47

$
60

 
 
 
 
 
 
Beginning balance
$
(4,685
)
$
(5,810
)
 
$
(4,818
)
$
(6,134
)
AOCI before reclasses – net of taxes of $25, $13, $20 and $39
(58
)
(308
)
 
(613
)
(1
)
Reclasses from AOCI – net of taxes of $0, $0, $0 and $(4)(b)
1

167

 
691

284

AOCI
(57
)
(141
)
 
78

283

Less AOCI attributable to noncontrolling interests
1

(77
)
 
3

22

Currency translation adjustments AOCI ending balance
$
(4,743
)
$
(5,874
)
 
$
(4,743
)
$
(5,874
)
 
 
 
 
 
 
Beginning balance
$
(163
)
$
49

 
$
49

$
13

AOCI before reclasses – net of taxes of $(24), $(8), $(69) and $3
40

(50
)
 
(222
)
(16
)
Reclasses from AOCI – net of taxes of $(1), $4, $8 and $1(b)
13

25

 
64

28

AOCI
53

(25
)
 
(158
)
12

Less AOCI attributable to noncontrolling interests
—

(1
)
 
—

1

Cash flow hedges AOCI ending balance
$
(109
)
$
26

 
$
(109
)
$
26

 
 
 
 
 
 
Beginning balance
$
(5,991
)
$
(7,708
)
 
$
(7,024
)
$
(8,254
)
AOCI before reclasses – net of taxes of $(2), $13, $28 and $(35)
(74
)
7

 
145

(111
)
Reclasses from AOCI – net of taxes of $187, $164, $426 and $347(b)
678

632

 
1,495

1,294

AOCI
604

639

 
1,640

1,183

Less AOCI attributable to noncontrolling interests
—

(6
)
 
3

(8
)
Benefit plans AOCI ending balance
$
(5,387
)
$
(7,063
)
 
$
(5,387
)
$
(7,063
)
 
 
 
 
 
 
AOCI at June 30
$
(10,194
)
$
(12,852
)
 
$
(10,194
)
$
(12,852
)

(a) Included adjustments of $(2,229) million and $(1,054) million for the three months ended June 30, 2020 and 2019, respectively and $(962) million and $(2,011) million for the six months ended June 30, 2020 and 2019, respectively, related to insurance liabilities and annuity benefits in our run-off insurance operations to reflect the effects that would have been recognized had the related unrealized investment security gains been realized. See Note 12 for further information.
(b) The total reclassification from AOCI included $836 million, including currency translation of $688 million, net of taxes, for the six months ended June 30, 2020, related to the sale of our BioPharma business within our Healthcare segment.

In 2016, we issued $5,694 million of GE Series D preferred stock, which are callable on January 21, 2021. In addition to Series D, $250 million of existing GE Series A, B and C preferred stock are also outstanding. The total carrying value of GE preferred stock at June 30, 2020 was $5,826 million and will increase to $5,944 million by the respective call dates through periodic accretion. See our Annual Report on Form 10-K for the year ended December 31, 2019 for further information.

Noncontrolling interests in equity of consolidated affiliates amounted to $1,579 million and $1,545 million at June 30, 2020 and December 31, 2019, respectively.

Redeemable noncontrolling interests, presented within All other liabilities in our consolidated Statement of Financial Position, include common shares issued by our affiliates that are redeemable at the option of the holder of those interests and amounted to $474 million and $439 million as of June 30, 2020 and December 31, 2019, respectively.